Matthew Weiland
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Matthew Weiland has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Li Zhou
Center for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health, Detroit, MI 48202, USA
2 shared publications - Qing-Sheng Mi
Center for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health, Detroit, MI 48202, USA
2 shared publications - Jiajun Zhao
Shandong Provincial Hospital Affiliated to Shandong First Medical University
1 shared publication - Ling Gao
Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
1 shared publication - Min Liu
Key Laboratory of Immune Microenvironment and Disease of the Ministry of Education, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
1 shared publication - Wen-Bin Chen
Institute of Pharmacology; Shandong University School of Medicine; Jinan, China; Henry Ford Immunology Program; Henry Ford Health System; Detroit, MI USA; Department of Dermatology; Henry Ford Health System; Detroit, MI USA
1 shared publication
Latest Publications
- Open Access
- 1 April 2013
- Published by Taylor & Francis in Cell Cycle
- Vol. 12 (7) , 1151-1152
Deletion of miRNAs in bone marrow prevents streptozotocin-induced murine autoimmune diabetes but deletion of miR-155 does not
- 1 April 2013
- Published by Taylor & Francis in Cell Cycle
- Vol. 12 (7) , 1151-1152
Open AccessDeletion of miRNAs in bone marrow prevents streptozotocin-induced murine autoimmune diabetes but deletion of miR-155 does not
- 1 June 2012
- Published by Taylor & Francis in RNA Biology
- Vol. 9 (6) , 850-859
Small RNAs have a large impact
The highly conserved RNAs, microRNAs (miRNAs), are a class of small single stranded noncoding RNAs that function through translational repression of specific target mRNAs. miRNAs exhibit a wide range of involvement regulating gene expressions. miRNA expression dysregulated in cancer cells and damaged tissues from different diseases implicates a functional role of miRNAs in the disease development. More recently miRNAs have been detected in cell-free serum, and these circulating miRNAs can distinguish diseased individuals from healthy controls. The noninvasive nature of circulating miRNA collection and their sensitivity and specificity in diseases has encouraged a pursuit of miRNA biomarker research. As a result, approximately 100 circulating miRNAs have been identified as biomarkers for different diseases, and the number is growing. Here we review recently reported circulating miRNA biomarkers and discuss their values and challenges for the disease biomarkers.
- 1 June 2012
- Published by Taylor & Francis in RNA Biology
- Vol. 9 (6) , 850-859
Small RNAs have a large impact
The highly conserved RNAs, microRNAs (miRNAs), are a class of small single stranded noncoding RNAs that function through translational repression of specific target mRNAs. miRNAs exhibit a wide range of involvement regulating gene expressions. miRNA expression dysregulated in cancer cells and damaged tissues from different diseases implicates a functional role of miRNAs in the disease development. More recently miRNAs have been detected in cell-free serum, and these circulating miRNAs can distinguish diseased individuals from healthy controls. The noninvasive nature of circulating miRNA collection and their sensitivity and specificity in diseases has encouraged a pursuit of miRNA biomarker research. As a result, approximately 100 circulating miRNAs have been identified as biomarkers for different diseases, and the number is growing. Here we review recently reported circulating miRNA biomarkers and discuss their values and challenges for the disease biomarkers.